In women with obesity in the pooled liraglutide/exercise/placebo trial, further weight loss was linked to higher serum 25(OH)D than weight regain (14 nmol/L; 95% CI 6-22; P = .001).
In plain wordsIn women with obesity in the mixed-intervention trial including liraglutide, further weight loss was linked to higher vitamin D than weight regain.
- Peptide
- Liraglutide
- Outcome
- IncreaseSerum 25-hydroxyvitamin D by further weight-loss status
- Study
n: not reported in source
- Comparator
- Women regaining weight
- Outcome group
- Metabolic pathways and metabolomics · Endocrine and hormones
Measurements
- 25-hydroxyvitamin D difference
- 14 nmol/L
- further weight loss versus regain; 95% CI 6-22; P = .001; pooled treatment arms
Source sentences
Women who experienced a further weight loss during the 52 weeks of intervention had an increase in serum 25(OH)D compared with women regaining weight [14 nmol/L (95% CI 6-22); P = .001].
1 context sentence(design, population, supporting numbers)
Secondary analysis from a randomized placebo-controlled trial, designed to investigate the efficacy of 52 weeks of treatment with either liraglutide, exercise, or both combined compared with placebo on weight loss maintenance after an 8-week low-calorie diet-induced weight loss in 195 individuals wi…
In this study, Liraglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Liraglutide.